Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Inventory (2020 - 2025)

Pulmonx (LUNG) has disclosed Inventory for 6 consecutive years, with $16.2 million as the latest value for Q2 2025.

  • Quarterly Inventory fell 4.74% to $16.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $16.2 million through Jun 2025, down 4.74% year-over-year, with the annual reading at $16.9 million for FY2024, 1.03% up from the prior year.
  • Inventory for Q2 2025 was $16.2 million at Pulmonx, down from $16.8 million in the prior quarter.
  • The five-year high for Inventory was $19.2 million in Q2 2022, with the low at $13.4 million in Q2 2021.
  • Average Inventory over 5 years is $16.5 million, with a median of $16.7 million recorded in 2023.
  • The sharpest move saw Inventory surged 61.34% in 2021, then decreased 14.84% in 2023.
  • Over 5 years, Inventory stood at $16.3 million in 2021, then dropped by 4.4% to $15.6 million in 2022, then rose by 7.55% to $16.7 million in 2023, then grew by 1.03% to $16.9 million in 2024, then fell by 4.37% to $16.2 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $16.2 million, $16.8 million, and $16.9 million for Q2 2025, Q1 2025, and Q4 2024 respectively.